Loopbaan van Michael M. Mueller
Eerdere bekende functies van Michael M. Mueller
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| VIRACTA THERAPEUTICS, INC. | Algemeen Adviseur | 01-05-2020 | 01-01-2022 |
| HISTOGEN INC. | Algemeen Adviseur | 01-01-2013 | - |
| Bedrijfssecretaris | 01-01-2013 | - |
Opleiding van Michael M. Mueller
| University of Minnesota | Undergraduate Degree |
| Thomas Jefferson School of Law | Graduate Degree |
| San Diego State University | Masters Business Admin |
Statistieken
Internationaal
| Verenigde Staten | 6 |
Operationeel
| General Counsel | 2 |
| Corporate Secretary | 1 |
| Undergraduate Degree | 1 |
Sectoraal
| Consumer Services | 4 |
| Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| VIRACTA THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Conatus Pharmaceuticals, Inc.
 Conatus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Conatus Pharmaceuticals, Inc. is a biotechnology company that focuses on the development and commercialization of novel medicines to treat chronic diseases. The firm engages in developing emricasan, an orally active pan-caspase inhibitor, for the treatment of patients with chronic liver disease and is designed to reduce the activities of human caspases. It also develops CTS-2090, an orally active selective caspase inhibitor, for diseases involving inflammasome pathways. The company was founded by Alfred P. Spada, Jennifer Giottonini Cayer, and Steven J. Mento on July 13, 2005 and is headquartered in San Diego, CA. | Health Technology |
- Beurs
- Insiders
- Michael M. Mueller
- Ervaring
